Efficacy of 5-aminolevulinic acid-mediated photodynamic therapy using light-emitting diodes in human colon cancer cells

Oncology Reports

Volumn 29, Issue 3, 2013, Pages 911-916

  Hatakeyama, Tomoya ^a   Murayama, Yasutoshi ^a   Komatsu, Shuhei ^a   Shiozaki, Atsushi ^a   Kuriu, Yoshiaki ^a   Ikoma, Hisashi ^a   Nakanishi, Masayoshi ^a   Ichikawa, Daisuke ^a   Fujiwara, Hitoshi ^a   Okamoto, Kazuma ^a   Ochiai, Toshiya ^a   Kokuba, Yukihito ^a   Inoue, Katsushi ^b   Nakajima, Motowo ^b   Otsuji, Eigo ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b SBI Pharmaceuticals Co   (Japan)

Author keywords

5 aminolevulinic acid; Colon cancer; Light emitting diode; Photodynamic therapy; Protoporphyrin IX

Indexed keywords

AMINOLEVULINIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL STRAIN HT29; COLON CANCER; CONTROLLED STUDY; DRUG CYTOTOXICITY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIGHT EMITTING DIODE; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; TUMOR XENOGRAFT;

AMINOLEVULINIC ACID; ANIMALS; ANTINEOPLASTIC AGENTS; CELL SURVIVAL; COLONIC NEOPLASMS; FEMALE; HT29 CELLS; HUMANS; INJECTIONS, INTRAPERITONEAL; LIGHT; MICE; MICE, INBRED BALB C; MICE, NUDE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84872766140     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2220     Document Type: Article

References (37)

1. Nitsche U, Maak M, Schuster T, et al: Prediction of prognosis is not improved by the seventh and latest edition of the TNM classification for colorectal cancer in a single-center collective. Ann Surg 254: 793-801, 2011.
2. Mulsow J, Merkel S, Agaimy A and Hohenberger W: Outcomes following surgery for colorectal cancer with synchronous peritoneal metastases. Br J Surg 98: 1785-1791, 2011.
3. Dougherty TJ, Gomer CJ, Henderson BW, et al: Photodynamic therapy. J Natl Cancer Inst 90: 889-905, 1998. (Pubitemid 28304157)
4. Peng Q, Warloe T, Berg K, et al: 5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges. Cancer 79: 2282-2308, 1997. (Pubitemid 27251011)
5. Ishizuka M, Abe F, Sano Y, et al: Novel development of 5-aminolevurinic acid (ALA) in cancer diagnoses and therapy. Int Immunopharmacol 11: 358-365, 2011.
6. Murayama Y, Harada Y, Imaizumi K, et al: Precise detection of lymph node metastases in mouse rectal cancer by using 5-aminolevulinic acid. Int J Cancer 125: 2256-2263, 2009.
7. Juzeniene A, Juzenas P, Ma LW, Iani V and Moan J: Effectiveness of different light sources for 5-aminolevulinic acid photo-dynamic therapy. Lasers Med Sci 19: 139-149, 2004. (Pubitemid 40174126)
8. Brancaleon L and Moseley H: Laser and non-laser light sources for photodynamic therapy. Lasers Med Sci 17: 173-186, 2002.
9. Tsai JC, Chiang CP, Chen HM, et al: Photodynamic therapy of oral dysplasia with topical 5-aminolevulinic acid and light-emitting diode array. Lasers Surg Med 34: 18-24, 2004.
10. Ickowicz Schwartz D, Gozlan Y, Greenbaum L, Babushkina T, Katcoff DJ and Malik Z: Differentiation-dependent photody-namic therapy regulated by porphobilinogen deaminase in B16 melanoma. Br J Cancer 90: 1833-1841, 2004. (Pubitemid 38725662)
11. Maier A, Tomaselli F, Matzi V, Rehak P, Pinter H and Smolle-Juttner FM: Photosensitization with hematoporphyrin derivative compared to 5-aminolaevulinic acid for photody-namic therapy of esophageal carcinoma. Ann Thorac Surg 72: 1136-1140, 2001. (Pubitemid 32937991)
12. Redondo P, Marquina M, Pretel M, Aguado L and Iglesias ME: Methyl-ALA-induced fluorescence in photodynamic diagnosis of basal cell carcinoma prior to Mohs micrographic surgery. Arch Dermatol 144: 115-117, 2008. (Pubitemid 351159405)
13. Amo T, Kawanishi N, Uchida M, et al: Mechanism of cell death by 5-aminolevulinic acid-based photodynamic action and its enhancement by ferrochelatase inhibitors in human histiocytic lymphoma cell line U937. Cell Biochem Funct 27: 503-515, 2009.
14. Inoue H, Kajimoto Y, Shibata MA, et al: Massive apoptotic cell death of human glioma cells via a mitochondrial pathway following 5-aminolevulinic acid-mediated photodynamic therapy. J Neurooncol 83: 223-231, 2007. (Pubitemid 46952232)
15. Kim CH, Chung CW, Choi KH, et al: Effect of 5-aminolevulinic acid-based photodynamic therapy via reactive oxygen species in human cholangiocarcinoma cells. Int J Nanomed 6: 1357-1363, 2011.
16. Wakui M, Yokoyama Y, Wang H, Shigeto T, Futagami M and Mizunuma H: Efficacy of a methyl ester of 5-aminolevulinic acid in photodynamic therapy for ovarian cancers. J Cancer Res Clin Oncol 136: 1143-1150, 2010.
17. Morton CA, McKenna KE and Rhodes LE: Guidelines for topical photodynamic therapy: update. Br J Dermatol 159: 1245-1266, 2008.
18. Braathen LR, Szeimies RM, Basset-Seguin N, et al: Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005. J Am Acad Dermatol 56: 125-143, 2007. (Pubitemid 44969292)
19. Apalla Z, Sotiriou E, Chovarda E, Lefaki I, Devliotou-Panagiotidou D and Ioannides D: Skin cancer: preventive photodynamic therapy in patients with face and scalp cancerization. A randomized placebo-controlled study. Br J Dermatol 162: 171-175, 2010.
20. Messmann H, Geisler M, Gross U, et al: Influence of a haema-toporphyrin derivative on the protoporphyrin IX synthesis and photodynamic effect after 5-aminolaevulinic acid sensitization in human colon carcinoma cells. Br J Cancer 76: 878-883, 1997. (Pubitemid 27401938)
21. Brunner H, Hausmann F, Krieg RC, et al: The effects of 5-aminolevulinic acid esters on protoporphyrin IX production in human adenocarcinoma cell lines. Photochem Photobiol 74: 721-725, 2001.
22. Calin MA, Diaconeasa A, Savastru D and Tautan M: Photo-sensitizers and light sources for photodynamic therapy of the Bowen's disease. Arch Dermatol Res 303: 145-151, 2011.
23. van den Boogert J, van Staveren HJ, de Bruin RW, Eikelaar JH, Siersema PD and van Hillegersberg R: Photodynamic therapy for esophageal lesions: selectivity depends on wavelength, power, and light dose. Ann Thorac Surg 68: 1763-1769, 1999.
24. Prahl S: Optical Absorption of Hemoglobin. The Oregon Medical Laser Center, 1991. http://omlc.ogi.edu/spectra/hemoglobin/.
25. Jacques SL: Melanosome absorption coefficient. The Oregon Medical Laser Center, 1998. http://omlc.ogi.edu/spectra/melanin/mua.html.
26. Moan J, Iani V and Ma LW: Choice of the proper wavelength for photochemotherapy. Proc SPIE 45: 1608-1610, 1996.
27. Ma L, Bagdonas S and Moan J: The photosensitizing effect of the photoproduct of protoporphyrin IX. J Photochem Photobiol B 60: 108-113, 2001. (Pubitemid 32747241)
28. Hellinger MD and Santiago CA: Reoperation for recurrent colorectal cancer. Clin Colon Rectal Surg 19: 228-236, 2006. (Pubitemid 44865219)
29. Fuzun M, Terzi C, Sokmen S, Unek T and Haciyanli M: Potentially curative resection for locoregional recurrence of colorectal cancer. Surg Today 34: 907-912, 2004. (Pubitemid 40326467)
30. Baca B, Beart RW Jr and Etzioni DA: Surveillance after colorectal cancer resection: a systematic review. Dis Colon Rectum 54: 1036-1048, 2011.
31. Sadeghi B, Arvieux C, Glehen O, et al: Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer 88: 358-363, 2000. (Pubitemid 30051820)
32. Verwaal VJ, van Ruth S, de Bree E, et al: Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 21: 3737-3743, 2003. (Pubitemid 46606227)
33. Benizri EI, Bernard JL, Rahili A, Benchimol D and Bereder JM: Small bowel involvement is a prognostic factor in colorectal carcinomatosis treated with complete cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy. World J Surg Oncol 10: 56, 2012.
34. Kriegmair M, Baumgartner R, Knuechel R, et al: Fluorescence photodetection of neoplastic urothelial lesions following intravesical instillation of 5-aminolevulinic acid. Urology 44: 836-841, 1994.
35. Adam C, Salomon G, Walther S, et al: Photodynamic diagnosis using 5-aminolevulinic acid for the detection of positive surgical margins during radical prostatectomy in patients with carcinoma of the prostate: a multicentre, prospective, phase 2 trial of a diagnostic procedure. Eur Urol 55: 1281-1288, 2009.
36. Hoda MR and Popken G: Surgical outcomes of fluorescence-guided laparoscopic partial nephrectomy using 5-aminolevulinic acid-induced protoporphyrin IX. J Surg Res 154: 220-225, 2009.
37. Gahlen J, Prosst RL, Pietschmann M, et al: Laparoscopic fluo-rescence diagnosis for intraabdominal fluorescence targeting of peritoneal carcinosis experimental studies. Ann Surg 235: 252-260, 2002. (Pubitemid 34111955)